Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francoise Giguel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Virological Methods|July 6, 2010
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolatesNina H Lin, Daniel M Negusse, Rameen Beroukhim, et al.
Virology|September 8, 2012
Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype CNina H Lin, Carlos Becerril, Francoise Giguel, et al.
AIDS (London, England)|April 18, 2003
Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infectionCecile L Tremblay, Jennifer L Hicks, Lorraine Sutton, et al.
Open Forum Infectious Diseases|March 4, 2015
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group StudyTimothy J Henrich, Paul J McLaren, Suhas S P Rao, et al.
The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.
Cell|February 17, 2024
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2aMarie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, et al.
Open Forum Infectious Diseases|August 25, 2021
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019James Regan, James P Flynn, Alexandra Rosenthal, et al.
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
Contemporary Clinical Trials|December 3, 2022
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trialEvelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Virological Methods|July 6, 2010
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolatesNina H Lin, Daniel M Negusse, Rameen Beroukhim, et al.
Virology|September 8, 2012
Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype CNina H Lin, Carlos Becerril, Francoise Giguel, et al.
AIDS (London, England)|April 18, 2003
Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infectionCecile L Tremblay, Jennifer L Hicks, Lorraine Sutton, et al.
Open Forum Infectious Diseases|March 4, 2015
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group StudyTimothy J Henrich, Paul J McLaren, Suhas S P Rao, et al.
The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.
Cell|February 17, 2024
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2aMarie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, et al.
Open Forum Infectious Diseases|August 25, 2021
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019James Regan, James P Flynn, Alexandra Rosenthal, et al.
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
Contemporary Clinical Trials|December 3, 2022
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trialEvelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, et al.
Pageof 2